Abstract
A variety of imidazolones 1-34 derivatives were synthesized and tested for their antibacterial effects against Escherichia coli, Bacillus subtilis, Shigella flexnari, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi. Compound 18 found to be moderately active against S. flexnari, however, compounds 8, 11, 15, 21, 22, 25 showed to be moderate and compounds 31 and 34 exhibited good activities against P. aeruginosa. Compounds 7, 9, 12-14, 24-26, and 29 demonstrated good to excellent activity against S. typhi, while remaining compound did not show significant antibacterial activities. Compounds 7, 9, 12, 13, 14, 25, 26, 29 showed good activities against S. typhi. The antifungal activities of imidazolones were also determined against Trichophyton longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani, Candida glabrata and found that compounds showed varying degree of percentage inhibition.
Keywords: Synthesis, Imidazolone, Antifungal, Antibacterial activities
Letters in Drug Design & Discovery
Title: Synthesis and Antibacterial and Antifungal Activity of 5-Substituted Imidazolones
Volume: 6 Issue: 1
Author(s): Khalid Mohammed Khan, Uzma Rasool Mughal, Sadia Khan, Saira Khan, Shahnaz Perveen and M. Iqbal Choudhary
Affiliation:
Keywords: Synthesis, Imidazolone, Antifungal, Antibacterial activities
Abstract: A variety of imidazolones 1-34 derivatives were synthesized and tested for their antibacterial effects against Escherichia coli, Bacillus subtilis, Shigella flexnari, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhi. Compound 18 found to be moderately active against S. flexnari, however, compounds 8, 11, 15, 21, 22, 25 showed to be moderate and compounds 31 and 34 exhibited good activities against P. aeruginosa. Compounds 7, 9, 12-14, 24-26, and 29 demonstrated good to excellent activity against S. typhi, while remaining compound did not show significant antibacterial activities. Compounds 7, 9, 12, 13, 14, 25, 26, 29 showed good activities against S. typhi. The antifungal activities of imidazolones were also determined against Trichophyton longifusus, Candida albicans, Aspergillus flavus, Microsporum canis, Fusarium solani, Candida glabrata and found that compounds showed varying degree of percentage inhibition.
Export Options
About this article
Cite this article as:
Khan Mohammed Khalid, Mughal Rasool Uzma, Khan Sadia, Khan Saira, Perveen Shahnaz and Choudhary Iqbal M., Synthesis and Antibacterial and Antifungal Activity of 5-Substituted Imidazolones, Letters in Drug Design & Discovery 2009; 6 (1) . https://dx.doi.org/10.2174/157018009787158553
DOI https://dx.doi.org/10.2174/157018009787158553 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Natural Carriers for siRNA Delivery
Current Pharmaceutical Design The Role of Lymphotoxin Receptor Signaling in Diseases
Current Molecular Medicine Role of Cooperativity in Protein Folding and Protein Mosaic Assemblage Relevance for Protein Conformational Diseases
Current Protein & Peptide Science Editorial (Thematic Issue: Phytochemicals for Human Diseases: An Update)
Current Pharmaceutical Biotechnology The Endocannabinoid System in Ageing: A New Target for Drug Development
Current Drug Targets Non-peptide CRF-Receptor Antagonists: Allosterism, Kinetics and Translation to Efficacy in Human Disease
Current Molecular Pharmacology Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Current Topics in Medicinal Chemistry Current Neuropharmacological Interventions in Autism: Potential Drug Targets from Pre-clinical and Clinical Findings
Current Psychopharmacology Cathepsin D as a Promising Target for the Discovery of Novel Anticancer Agents
Current Cancer Drug Targets Cholinesterase Inhibitor 6-Chlorotacrine - In Vivo Toxicological Profile and Behavioural Effects
Current Alzheimer Research Screening of a Chemical Library by HT-G4-FID for Discovery of Selective G-quadruplex Binders
Current Pharmaceutical Design Ethosomes and its Applications in Transdermal Drug Delivery
Current Drug Therapy Ginkgolic Acids Confer Potential Anticancer Effects by Targeting Pro- Inflammatory and Oncogenic Signaling Molecules
Current Molecular Pharmacology Clinical Applications of Pinhole Single Photon Emission Tomography
Current Medical Imaging Emerging Roles of MicroRNA-22 in Human Disease and Normal Physiology
Current Molecular Medicine Enzymatic Targets in Trypanosoma brucei
Current Protein & Peptide Science Adverse Reactions Induced by Minocycline: A Review of Literature
Current Drug Safety Medicinal Electrochemistry: Integration of Electrochemistry, Medicinal Chemistry and Computational Chemistry
Current Medicinal Chemistry Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?
Current Drug Targets Imaging Amyloid Pathology in the Living Brain
Current Medical Imaging